| References |
|
|
Amos CI,
Wu X,
Broderick P et al.
(2008)
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.
Nature Genetics
40(5):
616–622.
|
|
|
Barnes PJ,
Shapiro SD and
Pauwels RA
(2003)
Chronic obstructive pulmonary disease: molecular and cellular mechanisms.
European Respiratory Journal
22(4):
672–688.
|
|
|
Brantly ML,
Paul LD,
Miller BH et al.
(1988)
Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.
American Review of Respiratory Disease
138(2):
327–336.
|
|
|
Brody JS and
Spira A
(2006)
Chronic obstructive pulmonary disease, inflammation and lung cancer.
Proceedings of the American Thoracic Society
3:
535–538.
|
|
|
Brogger J,
Steen VM,
Eiken HG,
Gulsvik A and
Bakke P
(2006)
Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.
European Respiratory Journal
27(4):
682–688.
|
|
|
Chappell S,
Daly L,
Morgan K et al.
(2006a)
The SERPINE2 gene and chronic obstructive pulmonary disease.
American Journal of Human Genetics
79(1):
184–186, author reply 186–187.
|
|
|
Chappell S,
Daly L,
Morgan K et al.
(2006b)
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease.
Human Mutation
27(1):
103–109.
|
|
|
Chappell S,
Daly L,
Morgan K et al.
(2007)
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD.
European Respiratory Journal
30(4):
810–812.
|
|
|
Chappell S,
Daly L,
Morgan K et al.
(2008)
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.
European Respiratory Journal
32(4):
931–937.
|
|
|
D'Armiento J,
Dalal SS,
Okada Y,
Berg RA and
Chada K
(1992)
Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.
Cell
71(6):
955–961.
|
|
|
DeMeo DL,
Hersh CP,
Hoffman EA et al.
(2007)
Genetic determinants of emphysema distribution in the national emphysema treatment trial.
American Journal of Respiratory and Critical Care Medicine
176(1):
42–48.
|
|
|
DeMeo DL,
Mariani T,
Bhattacharya S et al.
(2009)
Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene.
American Journal of Human Genetics
85(4):
493–502.
|
|
|
Demeo DL,
Mariani TJ,
Lange C et al.
(2006)
The SERPINE2 gene is associated with chronic obstructive pulmonary disease.
American Journal of Human Genetics
78(2):
253–264.
|
|
|
Gooptu B and
Lomas DA
(2008)
Polymers and inflammation: disease mechanisms of the serpinopathies.
Journal of Experimental Medicine
205(7):
1529–1534.
|
|
|
other
Hancock DB,
Eijgelsheim M,
Wilk JB et al.
(2009) Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Advance online publication doi:10.1038/ng.500.
|
|
|
Hassett C,
Aicher L,
Sidhu JS and
Omiecinski CJ
(1994)
Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.
Human Molecular Genetics
3(3):
421–428.
|
|
|
Hautamaki RD,
Kobayashi DK,
Senior RM and
Shapiro SD
(1997)
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.
Science (New York)
277(5334):
2002–2004.
|
|
|
Hersh CP,
Dahl M,
Ly NP et al.
(2004)
Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.
Thorax
59(10):
843–849.
|
|
|
Hersh CP,
Demeo DL,
Lange C et al.
(2005)
Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.
American Journal of Respiratory Cell and Molecular Biology
33(1):
71–78.
|
|
|
Hersh CP,
Demeo DL,
Lazarus R et al.
(2006)
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine
173(9):
977–984.
|
|
|
Hersh CP,
Hansel NN,
Barnes KC et al.
(2009)
Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema.
American Journal of Respiratory Cell and Molecular Biology
41:
324–331.
|
|
|
Hirano K,
Sakamoto T and
Uchida Y
(2001)
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.
European Respiratory Journal
18(5):
748–752.
|
|
|
other
Hosgood III HD,
Menashe I,
He X,
Chanock S and
Lan Q
(2009) PTEN identified as important risk factor of chronic obstructive pulmonary disease. doi:10.1016/j.rmed.2009.06.016.
|
|
|
Hung RJ,
McKay JD,
Gaborieau V et al.
(2008)
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.
Nature
452(7187):
633–637.
|
|
|
International HapMap Consortium
(2003)
The International HapMap Project.
Nature
426(6968):
789–796.
|
|
|
Joost O,
Wilk JB,
Cupples LA et al.
(2002)
Genetic loci influencing lung function: a genome-wide scan in the Framingham Study.
American Journal of Respiratory and Critical Care Medicine
165(6):
795–799.
|
|
|
Kalsheker NA,
Hodgson IJ,
Watkins GL et al.
(1987)
Deoxyribonucleic acid (DNA) polymorphism of the alpha 1-antitrypsin gene in chronic lung disease.
British Medical Journal (Clinical Research edition)
294(6586):
1511–1514.
|
|
|
Koshiol J,
Rotunno M,
Consonni D et al.
(2009)
Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.
PLoS One
4(10):
e7380.
|
|
|
Kueppers F,
Miller RD,
Gordon H,
Hepper NG and
Offord K
(1977)
Familial prevalence of chronic obstructive pulmonary disease in a matched pair study.
American Journal of Medicine
63(3):
336–342.
|
|
|
Lander E and
Kruglyak L
(1995)
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.
Nature Genetics
11(3):
241–247.
|
|
|
Mathers CD and
Loncar D
(2006)
Projections of global mortality and burden of disease from 2002 to 2030.
PLoS Medicine
3(11):
e442.
|
|
|
Matheson MC,
Raven J,
Walters EH,
Abramson MJ and
Ellis JA
(2006)
Microsomal epoxide hydrolase is not associated with COPD in a community-based sample.
Human Biology; An International Record of Research
78(6):
705–717.
|
|
|
McClearn GE,
Svartengren M,
Pedersen NL,
Heller DA and
Plomin R
(1994)
Genetic and environmental influences on pulmonary function in aging Swedish twins.
Journal of Gerontology
49(6):
264–268.
|
|
|
McCloskey SC,
Patel BD,
Hinchliffe SJ et al.
(2001)
Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction.
American Journal of Respiratory and Critical Care Medicine
164(8 part 1):
1419–1424.
|
|
|
Palmer LJ,
Celedon JC,
Chapman HA et al.
(2003)
Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease.
Human Molecular Genetics
12(10):
1199–1210.
|
|
|
Pillai SG,
Ge D,
Zhu G et al.
(2009)
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.
PLoS Genetics
5(3):
e1000421.
|
|
|
Poller W,
Meisen C and
Olek K
(1990)
DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease.
European Journal of Clinical Investigation
20(1):
1–7.
|
|
|
Rennard SI and
Vestbo J
(2006)
COPD: the dangerous underestimate of 15%.
Lancet
367(9518):
1216–1219.
|
|
|
other
Repapi E,
Sayers I,
Wain LV et al.
(2009) Genome-wide association study identifies five loci associated with lung function. Advance online publication doi:10.1038/ng.501.
|
|
|
Sandford AJ,
Spinelli JJ,
Weir TD and
Pare PD
(1997)
Mutation in the 3¢ region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease.
Journal of Medical Genetics
34(10):
874–875.
|
|
|
Schwartz AG and
Ruckdeschel JC
(2006)
Familial lung cancer.
Genetic Susceptibility and Relationship to Chronic Obstructive Pulmonary Disease
173:
16–22.
|
|
|
Silverman EK,
Chapman HA,
Drazen JM et al.
(1998)
Genetic epidemiology of severe, early onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
American Journal of Respiratory and Critical Care Medicine
157(6 part 1):
1770–1778.
|
|
|
Silverman EK,
Mosley JD,
Palmer LJ et al.
(2002a)
Genome-wide linkage analysis of severe, early onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes.
Human Molecular Genetics
11(6):
623–632.
|
|
|
Silverman EK,
Palmer LJ,
Mosley JD et al.
(2002b)
Genomewide linkage analysis of quantitative spirometric phenotypes in severe early onset chronic obstructive pulmonary disease.
American Journal of Human Genetics
70(5):
1229–1239.
|
|
|
Smith CA and
Harrison DJ
(1997)
Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.
Lancet
350(9078):
630–633.
|
|
|
Smolonska J,
Wijmenga C,
Postma DS and
Boezen HM
(2009)
Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years’ research.
American Journal of Respiratory and Critical Care Medicine
180(7):
618–631.
|
|
|
Spira A,
Beane J,
Pinto-Plata V et al.
(2004)
Gene expression profiling of human lung tissue from smokers with severe emphysema.
American Journal of Respiratory Cell and Molecular Biology
31(6):
601–610.
|
|
|
Spitz MR,
Amos CI,
Dong Q,
Lin J and
Wu X
(2008)
The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.
Journal of the National Cancer Institute
100(21):
1552–1556.
|
|
|
Sundberg K,
Johansson AS,
Stenberg G et al.
(1998)
Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons.
Carcinogenesis
19(3):
433–436.
|
|
|
Vibhuti A,
Arif E,
Deepak D,
Singh B and
Qadar Pasha MA
(2007)
Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD.
Biochemical and Biophysical Research Communications
359(1):
136–142.
|
|
|
Wang IM,
Stepaniants S,
Boie Y et al.
(2008)
Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer.
American Journal of Respiratory and Critical Care Medicine
177(4):
402–411.
|
|
|
Wilk JB,
Chen TH,
Gottlieb DJ et al.
(2009)
A genome-wide association study of pulmonary function measures in the Framingham Heart Study.
PLoS Genetics
5(3):
e1000429.
|
|
|
Wilk JB,
DeStefano AL,
Joost O et al.
(2003)
Linkage and association with pulmonary function measures on chromosome 6q27 in the Framingham Heart Study.
Human Molecular Genetics
12(21):
2745–2751.
|
|
|
Wilson AG,
Symons JA,
McDowell TL,
McDevitt HO and
Duff GW
(1997)
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.
Proceedings of the National Academy of Sciences of the USA
94(7):
3195–3199.
|
|
|
Yoshikawa M,
Hiyama K,
Ishioka S et al.
(2000)
Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese.
International Journal of Molecular Medicine
5(1):
49–53.
|
|
|
Young RP,
Hopkins RJ,
Hay BA et al.
(2008)
Lung cancer gene associated with COPD: triple whammy or possible confounding effect.
European Respiratory Journal
32:
1158–1164.
|
|
|
Zeskind JE,
Lenburg ME and
Spira A
(2008)
Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management.
Proceedings of the American Thoracic Society
5(8):
834–841.
|
|
|
Zhong L,
Fu WP,
Sun C,
Dai LM and
Zhang YP
(2009)
Absence of association between SERPINE2 genetic polymorphisms and chronic obstructive pulmonary disease in Han Chinese: a case-control cohort study.
BMC Medical Genetics
10:
66.
|
|
|
Zhu G,
Warren L,
Aponte J et al.
(2007)
The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations.
American Journal of Respiratory and Critical Care Medicine
176(2):
167–173.
|
| Further Reading |
|
|
Bhattacharya S and
Mariani TJ
(2009)
Array of hope: expression profiling identifies disease biomarkers and mechanism.
Biochemical Society Transactions
37(Pt 4):
855–862.
|
|
|
Marciniak SJ and
Lomas DA
(2009)
What can naturally occurring mutations tell us about the pathogenesis of COPD?
Thorax
64(4):
359–364.
|
|
|
Seifart C and
Plagens A
(2007)
Genetics of chronic obstructive pulmonary disease.
International Journal of Chronic Obstructive Pulmonary Disease
2(4):
541–550.
|
|
|
Wan ES and
Silverman EK
(2009)
Genetics of COPD and emphysema.
Chest
136(3):
859–866.
|
|
|
Yang IA and
Francis SM
(2009)
Deconstructing COPD using genomic tools.
Respirology (Carlton, Victoria)
14(3):
313–317.
|
